Cargando…

Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein

One of the most crucial characteristic traits of Envelope (E) proteins in the severe acute respiratory syndrome SARS-CoV-1 and NCOVID19 viruses is their membrane-associated oligomerization led ion channel activity, virion assembly, and replication. NMR spectroscopic structural studies of envelope pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Shruti, Harikishore, Amaravadhi, Bhunia, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859708/
https://www.ncbi.nlm.nih.gov/pubmed/33548321
http://dx.doi.org/10.1016/j.ijbiomac.2021.02.011
_version_ 1783646793164128256
author Mukherjee, Shruti
Harikishore, Amaravadhi
Bhunia, Anirban
author_facet Mukherjee, Shruti
Harikishore, Amaravadhi
Bhunia, Anirban
author_sort Mukherjee, Shruti
collection PubMed
description One of the most crucial characteristic traits of Envelope (E) proteins in the severe acute respiratory syndrome SARS-CoV-1 and NCOVID19 viruses is their membrane-associated oligomerization led ion channel activity, virion assembly, and replication. NMR spectroscopic structural studies of envelope proteins from both the SARS CoV-1/2 reveal that this protein assembles into a homopentamer. Proof of concept studies via truncation mutants on either transmembrane (VFLLV), glycosylation motif (CACCN), hydrophobic helical bundle (PVYVY) as well as replacing C-terminal “DLLV” segments or point mutants such as S68, E69 residues with cysteine have significantly reduced viral titers of SARS-CoV-1. In this present study, we have first developed SARS-2 E protein homology model based on the pentamer coordinates of SARS-CoV-1 E protein (86.4% structural identity) with good stereochemical quality. Next, we focused on the glycosylation motif and hydrophobic helical bundle regions of E protein shown to be important for viral replication. A four feature (4F) model comprising of an acceptor targeting S60 hydroxyl group, a donor feature anchoring the C40 residue, and two hydrophobic features anchoring the V47 L28, L31, Y55, and P51 residues formed the protein based pharmacophore model targeting the glycosylation motif and helical bundle of E protein. Database screening with this 4F protein pharmacophore, ADMET property filtering on enamine small molecule discovery collection yielded a focused library of ~7000 hits. Further molecular docking and visual inspection of docked pose interactions at the above mention V47 L28, L31, Y55, P51, S60, C40 residues led to the identification of 10 best hits. Our STD NMR binding assay results demonstrate that the ligand 3, 2-(2-amino-2-oxo-ethoxy)-N-benzyl-benzamide, binds to NCOVID19 E protein with a binding affinity (K(D)) of 141.7 ± 13.6 μM. Furthermore, the ligand 3 also showed binding to C-terminal peptide (NR25) as evidenced with the STD spectrums of wild type E protein would serve to confirm the involvement of C-terminal helical bundle as envisaged in this study.
format Online
Article
Text
id pubmed-7859708
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-78597082021-02-04 Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein Mukherjee, Shruti Harikishore, Amaravadhi Bhunia, Anirban Int J Biol Macromol Article One of the most crucial characteristic traits of Envelope (E) proteins in the severe acute respiratory syndrome SARS-CoV-1 and NCOVID19 viruses is their membrane-associated oligomerization led ion channel activity, virion assembly, and replication. NMR spectroscopic structural studies of envelope proteins from both the SARS CoV-1/2 reveal that this protein assembles into a homopentamer. Proof of concept studies via truncation mutants on either transmembrane (VFLLV), glycosylation motif (CACCN), hydrophobic helical bundle (PVYVY) as well as replacing C-terminal “DLLV” segments or point mutants such as S68, E69 residues with cysteine have significantly reduced viral titers of SARS-CoV-1. In this present study, we have first developed SARS-2 E protein homology model based on the pentamer coordinates of SARS-CoV-1 E protein (86.4% structural identity) with good stereochemical quality. Next, we focused on the glycosylation motif and hydrophobic helical bundle regions of E protein shown to be important for viral replication. A four feature (4F) model comprising of an acceptor targeting S60 hydroxyl group, a donor feature anchoring the C40 residue, and two hydrophobic features anchoring the V47 L28, L31, Y55, and P51 residues formed the protein based pharmacophore model targeting the glycosylation motif and helical bundle of E protein. Database screening with this 4F protein pharmacophore, ADMET property filtering on enamine small molecule discovery collection yielded a focused library of ~7000 hits. Further molecular docking and visual inspection of docked pose interactions at the above mention V47 L28, L31, Y55, P51, S60, C40 residues led to the identification of 10 best hits. Our STD NMR binding assay results demonstrate that the ligand 3, 2-(2-amino-2-oxo-ethoxy)-N-benzyl-benzamide, binds to NCOVID19 E protein with a binding affinity (K(D)) of 141.7 ± 13.6 μM. Furthermore, the ligand 3 also showed binding to C-terminal peptide (NR25) as evidenced with the STD spectrums of wild type E protein would serve to confirm the involvement of C-terminal helical bundle as envisaged in this study. Published by Elsevier B.V. 2021-04-01 2021-02-04 /pmc/articles/PMC7859708/ /pubmed/33548321 http://dx.doi.org/10.1016/j.ijbiomac.2021.02.011 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mukherjee, Shruti
Harikishore, Amaravadhi
Bhunia, Anirban
Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
title Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
title_full Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
title_fullStr Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
title_full_unstemmed Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
title_short Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein
title_sort targeting c-terminal helical bundle of ncovid19 envelope (e) protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859708/
https://www.ncbi.nlm.nih.gov/pubmed/33548321
http://dx.doi.org/10.1016/j.ijbiomac.2021.02.011
work_keys_str_mv AT mukherjeeshruti targetingcterminalhelicalbundleofncovid19envelopeeprotein
AT harikishoreamaravadhi targetingcterminalhelicalbundleofncovid19envelopeeprotein
AT bhuniaanirban targetingcterminalhelicalbundleofncovid19envelopeeprotein